載入...
Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors
Targeting neuroendocrine tumors expressing somatostatin receptor subtypes (sst) with radiolabeled somatostatin agonists is an established diagnostic and therapeutic approach in oncology. While agonists readily internalize into tumor cells, permitting accumulation of radioactivity, radiolabeled antag...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
National Academy of Sciences
2006
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1618814/ https://ncbi.nlm.nih.gov/pubmed/17056720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0607761103 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|